BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 15096513)

  • 1. Heterogeneous nuclear ribonuclear protein U associates with YAP and regulates its co-activation of Bax transcription.
    Howell M; Borchers C; Milgram SL
    J Biol Chem; 2004 Jun; 279(25):26300-6. PubMed ID: 15096513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner.
    Kim JH; Paek KY; Choi K; Kim TD; Hahm B; Kim KT; Jang SK
    Mol Cell Biol; 2003 Jan; 23(2):708-20. PubMed ID: 12509468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover.
    Xu N; Chen CY; Shyu AB
    Mol Cell Biol; 2001 Oct; 21(20):6960-71. PubMed ID: 11564879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RNA-binding selectivity of the RGG/RG motifs of hnRNP U is abolished by elements within the intrinsically disordered region.
    Kletzien OA; Wuttke DS; Batey RT
    bioRxiv; 2024 May; ():. PubMed ID: 38766111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear deformation regulates YAP dynamics in cancer associated fibroblasts.
    Emon B; Joy MSH; Lalonde L; Ghrayeb A; Doha U; Ladehoff L; Brockstein R; Saengow C; Ewoldt RH; Saif MTA
    Acta Biomater; 2024 Jan; 173():93-108. PubMed ID: 37977292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel somatic single nucleotide variants within the RNA binding protein hnRNP A1 in multiple sclerosis patients.
    Lee S; Levin M
    F1000Res; 2014; 3():132. PubMed ID: 25254102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subset of nuclear receptor coregulators act as coupling proteins during synthesis and maturation of RNA transcripts.
    Auboeuf D; Dowhan DH; Dutertre M; Martin N; Berget SM; O'Malley BW
    Mol Cell Biol; 2005 Jul; 25(13):5307-16. PubMed ID: 15964789
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular population dynamics of DNA structures in a bcl-2 promoter sequence is regulated by small molecules and the transcription factor hnRNP LL.
    Cui Y; Koirala D; Kang H; Dhakal S; Yangyuoru P; Hurley LH; Mao H
    Nucleic Acids Res; 2014 May; 42(9):5755-64. PubMed ID: 24609386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of the Hippo pathway by adherens junctions and apical-basal cell polarity modules.
    Yang CC; Graves HK; Moya IM; Tao C; Hamaratoglu F; Gladden AB; Halder G
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1785-90. PubMed ID: 25624491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippo pathway effector Yap promotes cardiac regeneration.
    Xin M; Kim Y; Sutherland LB; Murakami M; Qi X; McAnally J; Porrello ER; Mahmoud AI; Tan W; Shelton JM; Richardson JA; Sadek HA; Bassel-Duby R; Olson EN
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13839-44. PubMed ID: 23918388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP1 increases organ size and expands undifferentiated progenitor cells.
    Camargo FD; Gokhale S; Johnnidis JB; Fu D; Bell GW; Jaenisch R; Brummelkamp TR
    Curr Biol; 2007 Dec; 17(23):2054-60. PubMed ID: 17980593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product.
    Sudol M
    Oncogene; 1994 Aug; 9(8):2145-52. PubMed ID: 8035999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct and overlapping functions of YAP and TAZ in tooth development and periodontal homeostasis.
    Ma J; Fan H; Geng H
    Front Cell Dev Biol; 2023; 11():1281250. PubMed ID: 38259513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordant interactions between YAP1 and polycomb group protein SCML2 determine cell fate.
    Boston AM; Dwead AM; Al-Mathkour MM; Khazaw K; Zou J; Zhang Q; Wang G; Cinar B
    iScience; 2023 Oct; 26(10):107964. PubMed ID: 37810219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into recent findings and clinical application of YAP and TAZ in cancer.
    Franklin JM; Wu Z; Guan KL
    Nat Rev Cancer; 2023 Aug; 23(8):512-525. PubMed ID: 37308716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biology of YAP in programmed cell death.
    Cheng Y; Mao M; Lu Y
    Biomark Res; 2022 May; 10(1):34. PubMed ID: 35606801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hnRNPU in Sertoli cells cooperates with WT1 and is essential for testicular development by modulating transcriptional factors
    Wen Y; Ma X; Wang X; Wang F; Dong J; Wu Y; Lv C; Liu K; Zhang Y; Zhang Z; Yuan S
    Theranostics; 2021; 11(20):10030-10046. PubMed ID: 34815802
    [No Abstract]   [Full Text] [Related]  

  • 18. Riluzole-induced apoptosis in osteosarcoma is mediated through Yes-associated protein upon phosphorylation by c-Abl Kinase.
    Raghubir M; Azeem SM; Hasnat R; Rahman CN; Wong L; Yan S; Huang YQ; Zhagui R; Blyufer A; Tariq I; Tam C; Lhamo S; Cecilio L; Chowdhury Y; ChandThakuri S; Mahajan SS
    Sci Rep; 2021 Oct; 11(1):20974. PubMed ID: 34697383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP facilitates melanoma migration through regulation of actin-related protein 2/3 complex subunit 5 (ARPC5).
    Lui JW; Moore SPG; Huang L; Ogomori K; Li Y; Lang D
    Pigment Cell Melanoma Res; 2022 Jan; 35(1):52-65. PubMed ID: 34468072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
    Song H; Li D; Wang X; Fang E; Yang F; Hu A; Wang J; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
    J Hematol Oncol; 2020 Mar; 13(1):24. PubMed ID: 32216806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.